Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Blog updated 12/22/2022
Blog updated 12/22/2022
Resource updated 03/15/2023
Blog updated 08/19/2022
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource updated 03/26/2024
Resource updated 10/24/2023
Blog updated 03/28/2024
Resource updated 09/14/2023
This presentation will share innovative strategies in the creation of a reflective Consumer Advisory Board, HIT HIV. The presentation will showcase quality improvement projects the HIT HIV CAB completed while leveraging technology, social media, consumer feedback, and CQM principles ensuring a community-driven and equitable process toward ending the HIV epidemic.
Resource (Conference Presentation) updated 09/14/2023
Max Clinic's multi-agency partnership to address the complex medical and social needs of people with HIV by utilizing a multidisciplinary approach involving case management, field work, and comprehensive medical services to reach people with HIV who are not currently engaged in HIV care.
Resource (Conference Presentation) updated 09/14/2023
The Spanish language community advisory board (SCAB) approach was to create horizontal and vertical community entity linkages and understand the nature of institutional interactions. The SCAB facilitates community involvement in patient care and support to improve implementation and sustainability of the HIV prevention and control strategies.
Resource (Conference Presentation) updated 09/14/2023
The purpose of this curriculum is to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
It provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Resource updated 03/12/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024